Amaro Therapeutics, Inc.

Amaro Therapeutics is building the preeminent biotechnology company around medicine’s first ‘therapeutic’ targets – extra-oral bitter taste receptors – to develop therapies for the treatment of metabolic and immunologic diseases and conditions.

Address

Visit website (opens in a new tab)
Loading